Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPets at home Regulatory News (PETS)

Share Price Information for Pets at home (PETS)

Share Price is delayed by 15 minutes
Get Live Data
183.40    -2.40 (-1.29%)
Bid:
182.00
Ask:
184.10
Spread: 2.10 (1.154%)
Market Cap: £811.14m
PETS Live PriceLast checked at - London Stock Exchange

Intraday Pets at home Share Chart

Director/PDMR Shareholding

29 Sep 2017 07:28

RNS Number : 2074S
Pets At Home Group Plc
29 September 2017
 

29 September 2017

Notification of Transaction of PDMR

 

Pets at Home Group Plc

 

Pets at Home Group Plc ("the Company") makes the following announcement regarding one of its Persons Discharging Managerial Responsibility's (PDMR) participation in the Company's Sharesave Plan ("Sharesave")

 

The Sharesave Plan is a tax advantaged share option plan available to all of the Company's employees, subject to qualifying conditions. It offers the opportunity for employees to buy ordinary shares of 1 pence each ("Share") in the Company using savings accumulated over a three year period.

 

The PDMR detailed below has elected to cancel his participation in the 2016 offer of Sharesave, resulting in the lapsing of the options originally granted to him on 11th October 2016 with an exercise price of £1.97 per Share. The options would have become exercisable on 1st December 2019. 4,550 options lapsed. The notification of dealing form for the PDMR can be found below.

 

1

Details of the person discharging managerial responsibilities/person closely associated

 

a)

Name

 

Peter Pritchard

2

Reason for the notification

 

a)

Position/status

Chief Executive of the Retail Division

 

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Pets at Home Group Plc

b)

LEI

N/A

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

 

Identification code

Options over Ordinary shares of 1 pence each in Pets at Home Group Plc

 

 

ISIN GB00BJ62K685

b)

Nature of the Transaction

Peter Pritchard cancelled his participation in the 2016 offer under the Pets at Home Group Sharesave Scheme and discontinued his monthly contributions resulting in the lapsing of the Options originally granted to him on the 11th October 2016 with an exercise price of £1.97 per Share. The Sharesave is a tax advantaged share scheme offered to all eligible employees of the Company.

 

c)

Price(s) and volume(s)

Price(s)

Volume(s)

 

 

£1.97

4,550

d)

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

 

Price

 

Aggregated volume

Aggregate Total

£1.97 per Share

4,550

£8,963.50

e)

Date of Transaction

28th September 2017

f)

Place of Transaction

London Stock Exchange (XLON)

 

This announcement is made in accordance with Article 19 of the Market Abuse Regulation and the Disclosure and Transparency Rules.

 

 

Persons responsible for arranging the release of this announcement

 

Louise Stonier

Group Legal Director and Company Secretary

Pets at Home Group Plc

Epsom Avenue

Stanley Green Trading Estate

Handforth

Cheshire

SK9 3RN

Tel: 0161 486 3590

Email: companysecretary@petsathome.co.uk

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHOKCDBABKKOCB
Date   Source Headline
27th May 20267:00 amRNSFY26 Preliminary Results
8th Apr 20261:47 pmRNSHolding(s) in Company
8th Apr 20267:00 amRNSTotal Voting Rights
31st Mar 20267:00 amRNSFY26 pre-close statement
3rd Mar 20267:00 amRNSTotal Voting Rights
27th Feb 20267:00 amRNSTransaction in Own Shares
26th Feb 20267:00 amRNSTransaction in Own Shares
25th Feb 20267:00 amRNSTransaction in Own Shares
24th Feb 20267:00 amRNSTransaction in Own Shares
23rd Feb 20267:00 amRNSTransaction in Own Shares
20th Feb 20267:00 amRNSTransaction in Own Shares
19th Feb 20267:00 amRNSTransaction in Own Shares
18th Feb 20267:00 amRNSTransaction in Own Shares
17th Feb 20267:00 amRNSTransaction in Own Shares
16th Feb 20267:00 amRNSTransaction in Own Shares
13th Feb 20267:00 amRNSTransaction in Own Shares
12th Feb 20267:00 amRNSTransaction in Own Shares
11th Feb 20267:00 amRNSTransaction in Own Shares
10th Feb 20267:00 amRNSTransaction in Own Shares
9th Feb 20267:00 amRNSTransaction in Own Shares
6th Feb 20267:00 amRNSTransaction in Own Shares
5th Feb 20267:00 amRNSTransaction in Own Shares
4th Feb 20267:00 amRNSTransaction in Own Shares
3rd Feb 20267:00 amRNSTransaction in Own Shares
2nd Feb 20267:00 amRNSTransaction in Own Shares
2nd Feb 20267:00 amRNSTotal Voting Rights
30th Jan 20267:00 amRNSTransaction in Own Shares
29th Jan 20267:00 amRNSTransaction in Own Shares
28th Jan 20267:00 amRNSQ3 FY26 Trading Statement
28th Jan 20267:00 amRNSTransaction in Own Shares
27th Jan 20267:00 amRNSTransaction in Own Shares
26th Jan 20267:00 amRNSTransaction in Own Shares
23rd Jan 20267:00 amRNSConfirmation of Board Changes
23rd Jan 20267:00 amRNSTransaction in Own Shares
22nd Jan 20267:00 amRNSTransaction in Own Shares
21st Jan 20267:00 amRNSTransaction in Own Shares
20th Jan 20267:00 amRNSTransaction in Own Shares
19th Jan 20267:00 amRNSTransaction in Own Shares
16th Jan 20267:00 amRNSTransaction in Own Shares
15th Jan 20267:00 amRNSTransaction in Own Shares
14th Jan 20267:00 amRNSTransaction in Own Shares
13th Jan 20267:00 amRNSTransaction in Own Shares
12th Jan 20267:00 amRNSTransaction in Own Shares
9th Jan 20267:00 amRNSTransaction in Own Shares
8th Jan 20267:00 amRNSTransaction in Own Shares
7th Jan 20267:00 amRNSTransaction in Own Shares
6th Jan 20267:00 amRNSTransaction in Own Shares
2nd Jan 20267:00 amRNSTotal Voting Rights
2nd Jan 20267:00 amRNSTotal Voting Rights
23rd Dec 20257:00 amRNSAppointment of CEO

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.